Literature DB >> 26516414

"Obesity paradox" in coronary artery disease.

Ibrahim Akin1, Christoph A Nienaber1.   

Abstract

Obesity used to be among the more neglected public health problems, but has unfolded as a growing medical and socioeconomic burden of epidemic proportions. Morbid obesity is linked to traditional cardiovascular risk factors like, hypertension, hyperlipidemia and diabetes, and suspected to incur increased morbidity and mortality in the Western and even third world populations. This patient cohort is also at greater risk to develop coronary artery disease. Recent population-based registries revealed that 43% and 24% of all cases of coronary revascularization were carried out in overweight and obese patients, respectively. However, despite evidence of a positive correlation between obesity and increased cardiovascular morbidity, some authors have described a better clinical outcome in overweight and obese patients, a phenomenon they coined "obesity paradoxon". Thus, there is an ongoing debate in light of conflicting data and the possibility of confounding bias causing misconception and challenging the "obesity paradox". In this review article we present the current evidence and throughly discuss the validity of the "obesity paradoxon" in a variety of clinical settings.

Entities:  

Keywords:  Body mass index; Coronary stent; Mortality; Obesity paradox

Year:  2015        PMID: 26516414      PMCID: PMC4620071          DOI: 10.4330/wjc.v7.i10.603

Source DB:  PubMed          Journal:  World J Cardiol


  52 in total

Review 1.  Guidelines for healthy weight.

Authors:  W C Willett; W H Dietz; G A Colditz
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

2.  No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.

Authors:  Ibrahim Akin; Ralph Tölg; Matthias Hochadel; Martin W Bergmann; Ahmed A Khattab; Steffen Schneider; Jochen Senges; Karl-Heinz Kuck; Gert Richardt; Christoph A Nienaber
Journal:  JACC Cardiovasc Interv       Date:  2012-02       Impact factor: 11.195

3.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.

Authors:  Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

4.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.

Authors:  Amir Halkin; Mandeep Singh; Eugenia Nikolsky; Cindy L Grines; James E Tcheng; Eulogio Garcia; David A Cox; Mark Turco; Thomas D Stuckey; Yingo Na; Alexandra J Lansky; Bernard J Gersh; William W O'Neill; Roxana Mehran; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

7.  Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).

Authors:  Robert M Minutello; Eric T Chou; Mun K Hong; Geoffrey Bergman; Manish Parikh; Frank Iacovone; S Chiu Wong
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

8.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

9.  Lack of "obesity paradox" in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysis.

Authors:  Ibrahim Akin; Henrik Schneider; Christoph A Nienaber; Werner Jung; Mike Lübke; Andreas Rillig; Uzair Ansari; Nina Wunderlich; Ralf Birkemeyer
Journal:  BMC Cardiovasc Disord       Date:  2015-07-11       Impact factor: 2.298

10.  Body mass index and hospital mortality in patients with acute coronary syndrome receiving care in a university hospital.

Authors:  Mercedes Camprubi; Sandra Cabrera; Jordi Sans; Georgina Vidal; Teresa Salvadó; Alfredo Bardají
Journal:  J Obes       Date:  2012-07-29
View more
  13 in total

1.  Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? Reply to Letter to the Editor.

Authors:  Edyane Cardoso Lopes; Isabela Heineck; Nelson Guardiola Meinhardt; Airton Tetelbom Stein
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

2.  Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.

Authors:  Anna Lareida; Robert Terziev; Bettina Grossenbacher; Nicolaus Andratschke; Patrick Roth; Sabine Rohrmann; Rolf Stahel; Matthias Guckenberger; Emilie Le Rhun; Michael Weller; Fabian Wolpert
Journal:  J Neurooncol       Date:  2019-09-30       Impact factor: 4.130

Review 3.  The Multifaceted Actions of Curcumin in Obesity.

Authors:  Vanessa Bianconi; Matteo Pirro; Seyed Mohammad Hassan Moallem; Muhammed Majeed; Paola Bronzo; Marco D'Abbondanza; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Identification of Key Genes as Early Warning Signals of Acute Myocardial Infarction Based on Weighted Gene Correlation Network Analysis and Dynamic Network Biomarker Algorithm.

Authors:  Chenxi Song; Zheng Qiao; Luonan Chen; Jing Ge; Rui Zhang; Sheng Yuan; Xiaohui Bian; Chunyue Wang; Qianqian Liu; Lei Jia; Rui Fu; Kefei Dou
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 5.  Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

Authors:  Taher Mandviwala; Umair Khalid; Anita Deswal
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

6.  Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study.

Authors:  Monika Puzianowska-Kuźnicka; Magdalena Owczarz; Katarzyna Wieczorowska-Tobis; Pawel Nadrowski; Jerzy Chudek; Przemyslaw Slusarczyk; Anna Skalska; Marta Jonas; Edward Franek; Malgorzata Mossakowska
Journal:  Immun Ageing       Date:  2016-06-03       Impact factor: 6.400

7.  Augmentation index (AI) in a dose-response relationship with smoking habits in males: The Tanushimaru study.

Authors:  Tomoko Tsuru; Hisashi Adachi; Mika Enomoto; Ako Fukami; Eita Kumagai; Sachiko Nakamura; Yume Nohara; Shoko Kono; Erika Nakao; Akiko Sakaue; Nagisa Morikawa; Yoshihiro Fukumoto
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Elevated fasting blood glucose, but not obesity, is associated with coronary artery disease in patients undergoing elective coronary angiography in a referral hospital in Jordan.

Authors:  Abdel-Ellah Al-Shudifat; Mohammed Azab; Asgeir Johannessen; Amjad Al-Shdaifat; Lana M Agraib; Reema F Tayyem
Journal:  Ann Saudi Med       Date:  2018 Mar-Apr       Impact factor: 1.526

Review 9.  Obesity paradox in patients undergoing coronary intervention: A review.

Authors:  Nirav Patel; Ossama Elsaid; Abhishek Shenoy; Abhishek Sharma; Samy I McFarlane
Journal:  World J Cardiol       Date:  2017-09-26

10.  High-sensitivity C-reactive protein as a prognostic marker in patients undergoing valve surgery.

Authors:  Piotr Duchnowski; Piotr Szymański; Mariusz Kuśmierczyk; Tomasz Hryniewiecki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.